DW Bartlett, C Friedrich, M Reed, R Baillie

Application of a physiologically based model incorporating drug-specific PK modules to support optimization of GLP-1 receptor agonist combination therapies for type 2 diabetes

Presented at American Association of Pharmaceutical Scientists (AAPS), 2013

E Hussey, J Cote-Sierra, H Hofland, V Damian-lordache, T Wilde, W Chern, C Friedrich, R Baillie

Physiological model to investigate and prioritize targets for psoriasis

 Presented by Stiefel and Rosa at American Conference on Pharmacometrics (ACoP), 2013, and at American Association of Pharmaceutical Scientists (AAPS) 2013

 E Kang, T Wilde, V Damian-lordache, E Hussey, C Friedrich, R Baillie, W Chern

Mechanistic and quantitative physiological models for the evaluation and prioritization of dermatology disease targets

Presented by Stiefel and Rosa at American Society for Clinical Pharmacology and Therapeutics (ASCPT), 2013

C Friedrich, R Baillie

Virtual Combination Therapy in Virtual NSCLC Tumor Cells Supports Strategic Development and Treatment Decisions

Presented at Keystone Symposia, Cancer and Metabolism, 2013

Oral Presentation

R Baillie, C Friedrich, M Reed

Using Formal Qualitative Modeling in Drug Development

Presented at American Conference on Pharmacometrics (ACoP), 2013

Oral Presentation

MJ Reed

Application of Mechanistic Physiological Modeling in the Drug Development Process – Overview and Case Studies

Presented at 28th Japanese Society for the Study of Xenobiotics (JSSX) Annual Meeting on Drug Metabolism and Pharmacokinetics, 2013

Oral Presentation

R Beaver

Accomplishments and Challenges in Systems Pharmacology

Presented at Hanson Wade Integrating Pharmacometrics Summit, 2013

Oral Presentation

T Gordi

Models and Their Utility in the Drug Development Process

Presented at American Association of Pharmaceutical Scientists (AAPS) Bay Area Development Group (BADG), 2013

"I am grateful to our many clients who have challenged us over the past 15 years to conduct PhysioPD Research on the frontier of science."
—Ron Beaver, PhD, Founder, CEO
Learn more about PhysioPD

To download/watch webinars and stay informed about upcoming webinars, please fill out and submit your information.

Note that this information will not be provided in any form to any third parties.

You now have access to past Rosa's Worldwide Webinars. 

Each session includes a presentation and short discussion and lasts about 1 hour

Looks like there is an issue with the sign in form. Contact us directly and we'll look into the issue.  webinar@rosaandco.com

Complete the form below and receive monthly alerts on "Impact of Modeling & Simulation in Drug Development" webinars and QSP news.

You are now subscribed.

Looks like there is an issue with the mailing list subscription form. Contact us directly and we'll look into the issue.  webinar@rosaandco.com